药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Paricalcitol
Fibrinolysin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Fibrinolysin.
Paricalcitol
Beraprost
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Beraprost.
Paricalcitol
Ancrod
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Ancrod.
Paricalcitol
Defibrotide
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Defibrotide.
Paricalcitol
Desmoteplase
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Desmoteplase.
Paricalcitol
Ximelagatran
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Ximelagatran.
Paricalcitol
Coumarin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Coumarin.
Paricalcitol
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with 4-hydroxycoumarin.
Paricalcitol
Epoprostenol
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Epoprostenol.
Paricalcitol
Enoxaparin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Enoxaparin.
Paricalcitol
Heparin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Heparin.
Paricalcitol
Phenprocoumon
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Phenprocoumon.
Paricalcitol
Abiraterone
The serum concentration of Aminophenazone can be increased when it is combined with Abiraterone.
Paricalcitol
Tenofovir
Aminophenazone may increase the nephrotoxic activities of Tenofovir.
Paricalcitol
Tenofovir alafenamide
Aminophenazone may increase the nephrotoxic activities of Tenofovir alafenamide.
Paricalcitol
Pralatrexate
Aminophenazone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Paricalcitol
Lithium hydroxide
Aminophenazone may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Paricalcitol
Lithium carbonate
Aminophenazone may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Paricalcitol
Lithium citrate
Aminophenazone may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
Paricalcitol
Hydralazine
Aminophenazone may decrease the antihypertensive activities of Hydralazine.